Meeting
2023 ASCO Genitourinary Cancers Symposium
Incidence and survival in patients with urachal carcinoma: Cancer registry analysis between 2008 and 2019.
Authors
Christopher Darr
Department of Urology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Christopher Darr , Lennart Möller , Niklas Schürger , Tibor Szarvas , Henning Reis , Andreas Stang , Boris A. Hadaschik , Hiltraud Kajüter , Viktor Grünwald
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 480)
DOI
10.1200/JCO.2023.41.6_suppl.480
Abstract #
480
Poster Bd #
J2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Assessing tumor-infiltrating immune cells and outcomes with cisplatin- versus carboplatin-based treatment in advanced urothelial cancer (UC): Survival analysis of three platinum-treated UC cohorts.
First Author: Konrad Stawiski
Poster
2023 ASCO Annual Meeting
A nationwide population based primary CNS lymphoma (PCNSL) analysis: Do Hispanics have better outcomes?
First Author: Ysaith Orellana
Poster
2020 Gastrointestinal Cancers Symposium
Incidence and survival patterns of pancreatic neuroendocrine tumors over the last two decades: A SEER database analysis.
First Author: Mohamad Bassam Sonbol
Poster
2019 ASCO Annual Meeting
Racial disparity in incidence and survival for gastrointestinal stromal tumors (GIST): An analysis of SEER database.
First Author: Mark Bilinyi Ulanja